![BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma | Bone Marrow Transplantation BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma | Bone Marrow Transplantation](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41409-018-0395-y/MediaObjects/41409_2018_395_Fig1_HTML.png)
BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma | Bone Marrow Transplantation
![Frontiers | Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation | Medicine Frontiers | Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation | Medicine](https://www.frontiersin.org/files/MyHome%20Article%20Library/608165/608165_Thumb_400.jpg)
Frontiers | Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation | Medicine
![Treatment of extensive chronic graft‐versus‐host disease with extracorporeal photochemotherapy - Bisaccia - 2006 - Journal of Clinical Apheresis - Wiley Online Library Treatment of extensive chronic graft‐versus‐host disease with extracorporeal photochemotherapy - Bisaccia - 2006 - Journal of Clinical Apheresis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c62b747d-ab6d-421c-9201-b8d2c2533db2/jca.v35.6.cover.jpg)
Treatment of extensive chronic graft‐versus‐host disease with extracorporeal photochemotherapy - Bisaccia - 2006 - Journal of Clinical Apheresis - Wiley Online Library
![High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working Party | Bone ... High-dose therapy with BEAC conditioning compared to BEAM conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: no differences in toxicity or outcome. A matched-control study of the EBMT-Lymphoma Working Party | Bone ...](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-018-0196-3/MediaObjects/41409_2018_196_Fig1_HTML.jpg)